Training

Register now

Virtual meeting

Via Zoom
Visit the meeting URL

Description

This eight-hour course prepares physicians, nurse practitioners and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.

Intended audience

Physicians (MD, DO), Nurse Practitioners, Certified Nurse Midwifes (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants

Objectives

At the conclusion of BOTH PARTS this activity, participants should be able to:

• Screen and identify patients with OUD and define evidence-based treatments.
• Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
• Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
• Explain the process of buprenorphine induction as well as stabilization and maintenance.
• Discuss all FDA approved antagonist and agonist medications to treat OUD.
• Discuss basic office protocols including medical record documentation and confidentially.
• Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
• Recognize the importance of obtaining a waiver to begin treating patients with OUD.

Sponsored by

Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS). 
American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For more information, visit www.pcssNOW.org

Accreditation information

ACCME Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Boston University School of Medicine designates this live activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Register now